Skip to main content
Premium Trial:

Request an Annual Quote

Ambry to Use New RainDance Enrichment System for Targeted Sequencing


Ambry Genetics will be the first authorized service provider for a new high-throughput target enrichment system being developed by RainDance Technologies, the companies announced last week.

RainDance plans to officially launch the system, dubbed ThunderStorm, at the American Society of Human Genetics meeting next month.

ThunderStorm is an automated system that enables enrichment of up to 96 samples per day for targeted, high-throughput sequencing. The new system uses RainDance's microdroplet-based technology to process individual single molecule PCR reactions.

As reported by In Sequence's sister publication PCR Insider, RainDance's CEO Roopom Bannerjee said that the ThunderStorm will be able to complete a targeted resequencing protocol in about 15 minutes with no hands-on time, and will enable the company to offer sequence enrichment at between $100 and $150 per sample.

Additionally, RainDance said that the system can support a range of targeted sequencing applications including candidate gene lists, regions of association, signaling pathways, and deep sequencing of heterogeneous tumor samples.

Ambry's vice president of business development, Ardy Arianpour, said in a statement that the company plans to roll out a "portfolio of services based on this technology platform to our customers."

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.